Skip to content

Application of Ergogenic Aids to the Prehabilitation of Abdominal Cancer Patients Undergoing Cancer Surgery

Application of Ergogenic Aids to the Prehabilitation of Abdominal Cancer Patients Undergoing Cancer Surgery

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04073381
Enrollment
92
Registered
2019-08-29
Start date
2018-10-28
Completion date
2020-08-31
Last updated
2021-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prehabilitation

Keywords

Blood Flow Restriction Training, Ergogenic Aids, Abdominal Cancer

Brief summary

The purpose of the proposed study is to measure surgical recovery, including the length of hospital stay, incidence of perioperative complications, and mortality at 90 days post-surgery, in surgical patients with abdominal cancer. The investigators hypothesize that this prehabilitation program will improve recovery and reduce perioperative complications via the proposed prehabilitation intervention.

Detailed description

The investigators propose that steps to augment and optimize the effectiveness of prehabilitation interventions for abdominal cancer patients may be found in the field of sport science. The investigators have identified two primary strategies to improve and optimize prehabilitation in patients with abdominal cancer: exercise and nutritional supplementation. A home-based exercise program incorporating both walking and resistance training will be performed with blood flow restriction training (BFR). BFR is a cutting-edge training modality that works by restricting blood flow out of the veins by using compression devices similar to traditional blood pressure cuffs (1). This training modality is frequently used by injured athletes for enhanced recovery (2). Muscle hypertrophy and increased muscle strength are more robust and achievable with BFR, even if exercises are performed at low to moderate intensities (2). Additionally, the implementation of a sports nutrition supplement cocktail, which will be provided simultaneously with the 4-week BFR exercise intervention, was developed to augment the effects of resistance exercise by increasing overall anabolism (3) and to remedy the catabolic state that cancer patients often experience (4). The nutrition supplement cocktail will include whey protein, creatine monohydrate, and L-citrulline.

Interventions

COMBINATION_PRODUCTPrehabilitation Program

This is a 4 week prehabilitation program which uses both exercise and nutrition. Exercise will be prescribed at least 6 days a week. Three days a week , for 45 mins, participants will be asked to perform body, leg and arm exercises against light resistance while wearing pneumatic blood flow restriction arm and leg bands. minutes. On the alternate days participants will walk approximately 15 minutes while wearing the leg bands that restrict blood flow. Additionally, a nutrition supplement cocktail will be provided and should be taken every day within 1 hour after completing each exercise session. The 4 Week Nutrition (Sports Drink) Supplement Cocktail: will include whey protein (25 g/day), creatine monohydrate (8 g/day), and L-citrulline (5 g/day). The supplement mixture will be provided in daily packages by the investigators (nutrition supplements are not regulated by the FDA)

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

100 subjects between the ages of 18 and 90, who have GI cancer and will undergo surgery will be recruited for this study. 100 is an arbitrary number of participants. Due to this study design not being previously use before power analysis calculations were unable to made for key variables. All subjects will participate in the study design.

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients certified by a surgeon to participate in this study; * Patients between the ages of 18 and 90; * Patients with GI cancer.

Exclusion criteria

Patients with * Uncontrolled or active angina; * New York Heart Association Class 3 or 4 heart failure; * A myocardial infarction within the last 6 months; * Severe/ uncontrolled hypertension (systolic pressure ≥180 mmHg or diastolic pressure ≥120mmHg); * Uncontrolled diabetes (fasting blood glucose \>400 mg/dL); * American Society of Anesthesiologists (ASA) health status grade IV-V. * Severe orthopedic conditions that prohibit or impede exercise; * Wheelchair dependence; * Co-morbid medical conditions interfering with the ability to perform exercise; -Severely impaired ambulation (i.e. patients with uncontrolled neuromuscular disorders); * History of Acute Deep Venous Thrombosis within the last 6 months; * Inability to comply with exercise instructions upon evaluation; or * Inability to provide an informed consent (dementia); * Taking medication/supplements containing nitrites/nitrates; * With allergies to creatine monohydrate; * With allergies or intolerance to artificial sweeteners such as Sucralose, Xylitol, Aspartame, or Stevia; * Simultaneous participation in a pharmacotherapy trial; * Estimated glomerular filtration rate (EGFR) \< 30 and not currently on dialysis. * Pregnant or lactating women * Dementia * Mini Mental State Examination score of Severe Impairment (≤17), or * Patients with severe depression.

Design outcomes

Primary

MeasureTime frameDescription
Hospital Measures- Length of hospital stayThrough study completion, an average 1yearLength of hospital stay
Hospital Measures- Emergency room visitsThrough study completion, an average 1 yearemergency room visits
Hospital Measures- ReadmissionThrough study completion, an average 1 yearReadmission
Hospital MeasuresThrough study completion, an average 1 yearMortality

Secondary

MeasureTime frameDescription
Physical Fitness- SPPBBaseline and 4 weeksShort Physical Performance Battery Assessing Lower Extremity Function
Body CompositionBaseline and 4 weeksDXA (dual energy X-ray absorptiometry) will be used to assess body composition.
Blood Work- AABaseline and 4 weeksAmino Acids
Blood Work- CRPBaseline and 4 weeksC-Reactive protein (CRP)
Blood Work- IL6Baseline and 4 weeksInterleukin 6 (IL-6)
Blood Work- TNFalphaBaseline and 4 weeksTNF-alpha
Questionnaires- IPAQBaseline and 8 weeksInternational Physical Activity Questionnaire; self reported time, frequency and duration of physical activity within the last 7 days.
Questionnaires- SF36Baseline, 4 weeks, and 8 weeksSF-36 Quality of Life. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
Questionnaires- Health StatusBaselineHealth research questionnaire; self reported medical and health history of participant.
Questionnaires- FESIBaseline, 4 weeks, and 8 weeksFalls Efficacy Scale-International; items are summed to calculate a range of total score from minimum 16 to maximum 64. The higher the score the greater the fear of falling.
Questionnaires- NutritionBaselineDietary Food and Supplement Intake; self reported nutrition intake from 2 weekdays and one weekend.
Questionnaires- Charlson ComorbidityBaselineCharlson Comorbidity Index predicts the one-year mortality for a patient who may have a range of comorbid conditions, such as heart disease, AIDS, or cancer (a total of 22 conditions). Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of dying associated with each one. Scores are summed to provide a total score to predict mortality.
Questionnaires- BSCIBaselineBrief Screen for Cognitive Impairment (BSCI); Scores are weighted and summed to arrive at final score. Delayed recall and medication help each get a weight of 2.0, and errand help gets a weight of 1.0. If client does not take any medications, the weighted scores of the other two items perform similarly to the three-item version. Higher scores indicate greater frailty/cognitive impairment.
Questionnaires- Edmonton FrailtyBaselineEdmonton Frailty Assessment; consists of nine domains and eleven items, each scoring 0 points (frailty absent or normal health), 1 point (minor errors or mild/moderate impairment), or 2 points (important errors or severely impaired). Higher scores indicate greater frailty.
Questionnaires- ECOGBaselineEastern Cooperative Oncology Group Performance Status; Determines ability of patient to tolerate therapies in serious illness, specifically for chemotherapy.
Questionnaires- Clock TestBaselineClock Test; evaluates three items: correctly drawn clock shape, all numbers in the correct position, and hands of the clock set to the correct time. A score of 1 was assigned for each of these items. Higher scores indicate greater frailty/cognitive impairment.
AccerlometryThrough study completion, an average of one yearAccelerometer/ Pedometer Measurement will be used to measure activity levels for 7 days immediately post surgery.
Questionnaires- MMSEBaselineMini Mental State Examination (MMSE) 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. Score is reported as 0-30 . 24-30 indicates no cognitive impairment, 18-23 indicates mild cognitive impairment, and 0-17 indicates severe cognitive impairment.
Physical Fitness- Hand GripBaseline, 4 weeks, and 8 weeksHand grip dynamometry
Physical Fitness- 6MWTBaseline and 4 weeks6 minute walk test
Physical Fitness- TUGBaseline, 4 weeks, and 8 weeksTimed up and go

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026